JCJv Chen

Jv Chen

*This is an algorithmically generated author record based on publicly available information.

Jv Chen has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Bergenin attenuates osteoclast-mediated bone loss by modulating the SIRT1/NF-κB p65 signalling axis

    by Jv Chen, Wenyu Liao, Huaxin Wang, Peicong Chen, Peng Li, Chengshuo Huang, Hao Lin

  • Open Access

    Quality and reliability evaluation of chikungunya fever-related video content on Tiktok and Bilibili: A cross-sectional study

    by Chen Jv, Lu Zefeng, Liao Wenyu, Lin Hao, Chen Xinxin, Wang Shuangmiao

    Background: Chikungunya fever (CHIKF) is an arboviral disease caused by the Chikungunya virus, which has increasingly emerged as a global public health concern, particularly in regions like China. Short video platforms such as TikTok and Bilibili have become vital channels for disseminating health information. Given the significant reach of these platforms, it is essential to evaluate the quality and reliability of videos related to CHIKF, ensuring that the public receives accurate and credible information. Methods: This cross-sectional study collected the top 100 videos from each platform, ranked by comprehensive sorting. Video quality was assessed using four validated tools: the Global Quality Scale (GQS), modified DISCERN (mDISCERN), the Journal of the American Medical Association (JAMA) benchmarks, and the Video Information and Quality Index (VIQI), which evaluate educational, informational, and audiovisual quality. Results: A total of 166 videos were analyzed. Overall scores were at a moderate level: 3.00 (IQR: 2.00-4.00), mDISCERN 3.00 (IQR: 2.00-4.00), JAMA 2.00 (IQR: 2.00-2.00), and VIQI 10.00 (IQR: 8.00-13.00). Compared with Bilibili, TikTok videos demonstrated significantly higher user engagement, including likes, comments, and shares (all p p p <0.05). Conclusions: This study found that the overall quality, reliability, and transparency of CHIKF-related videos remain suboptimal. Videos uploaded by medical professionals performed best across multiple quality indicators. These findings highlight the need to strengthen content oversight on platforms and encourage medical professionals to actively participate in the creation of CHIKF-related science videos to improve the accuracy of public health information.

  • Open Access

    The quality and reliability of osteosarcoma information on TikTok and Bilibili: A cross-sectional study

    by Jv Chen, Zixin Luo, Wenyu Liao, Chengshuo Huang, Peng Li, Jinchang Zheng, Xinxin Chen, Hao Lin

    Background: Osteosarcoma is a rare and aggressive bone malignancy, yet public awareness remains insufficient. As social media platforms have become key sources of health information, this study aims to evaluate the quality and reliability of osteosarcoma-related videos on these platforms. Methods: This study collected 100 osteosarcoma-related videos from each platform, TikTok and Bilibili, based on their default ranking, resulting in 200 videos initially screened and 183 included after exclusions. Video characteristics were collected, including duration, likes, saves, comments, and shares. The Global Quality Scale (GQS) and Modified Discrimination Score (mDISCERN) were used to assess video quality and reliability. The completeness score (CS) was applied to evaluate five key aspects of the disease: etiology, clinical manifestations, diagnosis, treatment, and diagnosis. Finally, correlation analysis is carried out to explore the relationship among video features, audience engagement indicators, and video quality. Results: A total of 183 osteosarcoma-related videos were included. Clinical manifestations, treatment, and diagnosis were the most frequently addressed topics, whereas etiology and prognosis received comparatively less attention. TikTok videos had a median GQS of 2(Q1 = 2.00, Q3 = 3.00), a median mDISCERN of 3 (Q1 = 2.00, Q3 = 4.00), and a median CS of 4 (Q1 = 2.00, Q3 = 4.00). In contrast, Bilibili videos demonstrated higher quality, with a median GQS of 3 (Q2 = 2.00, Q3 = 3.00), a median mDISCERN of 3 (Q1 = 3.00, Q3 = 4.00), and a median CS of 4 (Q1 = 3.00, Q3 = 6.00). Videos produced by healthcare professionals achieved significantly higher scores compared to those uploaded by non-professionals ( p < 0.01). Spearman correlation analysis revealed no significant association between video features and quality scores. Conclusion: In conclusion, the overall quality and reliability of osteosarcoma-related videos on short video platforms were low. Videos uploaded by healthcare professionals and those on the Bilibili platform demonstrated relatively higher quality. These findings highlight the necessity of strengthening the regulation of health-related content on short video platforms and promoting greater involvement of healthcare professionals.


  • Open Access

    Upregulated BLM and RECQL4 in Osteosarcoma: Association with Poor Prognosis, Immune Cell Infiltration, and Inhibitory Effects of Sphingosine Kinase 1 Inhibitor II/Pilaralisib

    by Jv Chen, Yongli Situ, Jie Cai, Wenyu Liao, Dongbo Jiang, Chengshuo Huang, Jinchang Zheng, Lijiao Peng, Hao Lin

    Purpose: BLM and RECQL4, key RecQ helicases and “genome guardians”, maintain genomic stability. Their abnormal function/dysregulated expression is linked to tumorigenesis, but their roles in osteosarcoma (OS) remain unclear. Patients and Methods: Comprehensive bioinformatic analyses (multiple public databases) assess OS-related expression, gene networks, prognosis, targets, and drugs. Cellular experiments verified the effects of these compounds on 143B cell proliferation, migration, and invasion. Results: BLM and RECQL4 were significantly upregulated in OS tissues compared to normal tissues, correlating with a poor prognosis. Among the 153 patients with OS, 9% and 7% had altered BLM and RECQL4 expression, respectively. Abnormal methylation of BLM and RECQL4 may affect OS. BLM, RECQL4, and their altered neighboring genes (ANGs) form interaction networks that regulate tumor metabolism, proliferation, migration, and apoptosis. Their miRNA and kinase targets in OS were also identified. BLM and RECQL4 expression was negatively correlated with OS immune cell infiltration. In addition, anti–PD-1/CTLA-4/PD-L1 therapy, Sphingosine kinase 1 inhibitor II, and pilaralisib inhibited OS cell viability (by downregulating BLM or RECQL4) and the proliferation, migration, and invasion of 143B cells. Knockdown of BLM or RECQL4 suppressed the migration and invasion of 143B cells. Conclusion: BLM and RECQL4 are promising prognostic biomarkers and therapeutic targets for OS.


  • Open Access

    Systematic Analysis of CXC Chemokine–Vascular Endothelial Growth Factor A Network in Colonic Adenocarcinoma from the Perspective of Angiogenesis

    by Yongli Situ, Xiaoyong Lu, Yongshi Cui, Qinying Xu, Li Deng, Hao Lin, Zheng Shao, Jv Chen

    Background. Tumor angiogenesis plays a vital role in tumorigenesis, proliferation, and metastasis. Recently, vascular endothelial growth factor A (VEGFA) and CXC chemokines have been shown to play vital roles in angiogenesis. Exploring the expression level, gene regulatory network, prognostic value, and target prediction of the CXC chemokine‐VEGFA network in colon adenocarcinoma (COAD) is crucial from the perspective of tumor angiogenesis. Methods. In this study, we analyzed gene expression and regulation, prognostic value, target prediction, and immune infiltrates related to the CXC chemokine‐VEGFA network in patients with COAD using multiple databases (cBioPortal, UALCAN, Human Protein Atlas, GeneMANIA, GEPIA, TIMER (version 2.0), TRRUST (version 2), LinkedOmics, and Metascape). Results. Our results showed that CXCL1/2/3/5/6/8/11/16/17 and VEGFA were markedly overexpressed, while CXCL12/13/14 were underexpressed in patients with COAD. Moreover, genetic alterations in the CXC chemokine‐VEGFA network found at varying rates in patients with COAD were as follows: CXCL1/2/17 (2.1%), CXCL3/16 (2.6%), CXCL5/14 (2.4%), CXCL6 (3%), CXCL8 (0.8%), CXCL11/13 (1.9%), CXCL12 (0.6%), and VEGFA (1.3%). Promoter methylation of CXCL1/2/3/11/13/17 was considerably lower in patients with COAD, whereas methylation of CXCL5/6/12/14 and VEGFA was considerably higher. Furthermore, CXCL9/10/11 and VEGFA expression was notably correlated with the pathological stages of COAD. In addition, patients with COAD with high CXCL8/11/14 or low VEGFA expression levels survived longer than patients with dissimilar expression levels. CXC chemokines and VEGFA form a complex regulatory network through coexpression, colocalization, and genetic interactions. Moreover, many transcription factor targets of the CXC chemokine‐VEGFA network in patients with COAD were identified: RELA, NFKB1, ZFP36, XBP1, HDAC2, SP1, ATF4, EP300, BRCA1, ESR1, HIF1A, EGR1, STAT3, and JUN. We further identified the top three miRNAs involved in regulating each CXC chemokine within the network: miR‐518C, miR‐369‐3P, and miR‐448 regulated CXCL1; miR‐518C, miR‐218, and miR‐493 regulated CXCL2; miR‐448, miR‐369‐3P, and miR‐221 regulated CXCL3; miR‐423 regulated CXCL13; miR‐378, miR‐381, and miR‐210 regulated CXCL14; miR‐369‐3P, miR‐382, and miR‐208 regulated CXCL17; miR‐486 and miR‐199A regulated VEGFA. Furthermore, the CXC chemokine‐VEGFA network in patients with COAD was notably associated with immune infiltration. Conclusions. This study revealed that the CXC chemokine‐VEGFA network might act as a prognostic biomarker for patients with COAD. Moreover, our study provides new therapeutic targets for COAD, serving as a reference for further research in the future.